Response Biomedical Corp (RPBIF) SEC Filing 20-F Annual report for the fiscal year ending Thursday, December 31, 2009

Response Biomedical Corp

CIK: 806888 Ticker: RPBIF

View differences made from one year to another to evaluate Response Biomedical Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Response Biomedical Corp.


Assess how Response Biomedical Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Response Biomedical Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2010 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: RPBIF
CIK: 806888
Form Type: 20-F Annual Report
Accession Number: 0001157523-10-001860
Submitted to the SEC: Wed Mar 31 2010 5:44:27 PM EST
Accepted by the SEC: Thu Apr 01 2010
Period: Thursday, December 31, 2009
Industry: Testing Laboratories

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: